Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT02174939
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Registry
-
NCT02174939
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT02174939. Randomized; quadruple masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2017-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Cilostazol on Endothelial Progenitor Cells and Endothelial Function in Coronary Artery Disease
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Cilostazol
- Intervention (Drug)
- Dummy Placebo
- Lead sponsor
- National Cheng-Kung University Hospital
- Collaborator
- Department of Health, Executive Yuan, R.O.C. (Taiwan)
Record details
- Record id
cardio:ct-nct02174939- Content hash
3f3e8122381f806204c0dceda120b0511f8c2b8e32bf1d9f421ca3751f1da4cd